{"id":4402,"date":"2009-02-04T06:09:32","date_gmt":"2009-02-04T06:09:32","guid":{"rendered":"http:\/\/scienceblogs.com\/gregladen\/2009\/02\/04\/how-much-is-the-world-spending\/"},"modified":"2009-02-04T06:09:32","modified_gmt":"2009-02-04T06:09:32","slug":"how-much-is-the-world-spending","status":"publish","type":"post","link":"https:\/\/gregladen.com\/blog\/2009\/02\/04\/how-much-is-the-world-spending\/","title":{"rendered":"How much is the world spending on neglected disease research and development?"},"content":{"rendered":"

\"ResearchBlogging.org\"<\/a><\/span>How much are we actually spending on the development of pharmaceutical tools to treat HIV\/AIDS, TB, leichmaniasis, malaria and sleeping sickness?<\/p>\n

Today, PLoS Medicine Policy Forum asks this question. According to a press release from PLoS:<\/p>\n

The first comprehensive survey of global spending on neglected disease R&D, published in this week’s PLoS Medicine, finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases–HIV\/AIDS, TB, and malaria–receiving nearly 80% of the total.<\/p>\n

However, the survey finds that many neglected diseases, responsible for killing millions of people in developing countries, are significantly underfunded. <\/p><\/blockquote>\n


\nThe George Institute report indicates that aside from the big three (HIV, TB and malaria) most other diseases receive a very small percentage of available funding.<\/p>\n

Sleeping sickness, leishmaniasis and Chagas disease collectively received only 4.9% of total global funding; the diarrhoeal illnesses surveyed collectively received 4.5% of global funding; the helminth (worm) infections received 2%; and bacterial pneumonia and meningitis received only 1.3%. Five diseases – leprosy, Buruli ulcer, trachoma, rheumatic fever, and typhoid and paratyphoid fever – each received less than $10 million or 0.4% of total global investment. For many of these diseases, funding was not enough to create even one new product. <\/p><\/blockquote>\n

The George Institute study (by Moran and colleagues) was commissioned by the B&M Gates foundation. The study indicates that the US government provides about 75% of the total research funding in these areas, with the NIH providing a big chunk of that, and private sources such as Gates contributing substantial portions . Sadly, the study concludes that decisions as to where to carry out research are very much influenced by special interest groups and insufficiently influenced by a rational decision making process. Also, many of the worlds richest countries are simply not contributing to this effort a all.<\/p>\n

This is an OpenAccess publication, and you can find it here <\/a>, and there is a video here<\/a>.<\/p>\n

\n

Source
\nMoran, Mary, Guzman, J., Ropars, A., McDonald, A., Jameson, N., Omune, B., Ryan, S., Wu, L. (2009). Neglected Disease Research and Development:
\nHow Much Are We Really Spending?
\n PLoS Medicine Policy Forum<\/span> DOI: http:\/\/medicine.plosjournals.org\/perlserv\/?request=get-document&doi=10.1371\/journal.pmed.1000030<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

How much are we actually spending on the development of pharmaceutical tools to treat HIV\/AIDS, TB, leichmaniasis, malaria and sleeping sickness? Today, PLoS Medicine Policy Forum asks this question. According to a press release from PLoS: The first comprehensive survey of global spending on neglected disease R&D, published in this week’s PLoS Medicine, finds that … Continue reading How much is the world spending on neglected disease research and development?<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"1","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[103],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p5fhV1-190","jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/gregladen.com\/blog\/wp-json\/wp\/v2\/posts\/4402"}],"collection":[{"href":"https:\/\/gregladen.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gregladen.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gregladen.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gregladen.com\/blog\/wp-json\/wp\/v2\/comments?post=4402"}],"version-history":[{"count":0,"href":"https:\/\/gregladen.com\/blog\/wp-json\/wp\/v2\/posts\/4402\/revisions"}],"wp:attachment":[{"href":"https:\/\/gregladen.com\/blog\/wp-json\/wp\/v2\/media?parent=4402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gregladen.com\/blog\/wp-json\/wp\/v2\/categories?post=4402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gregladen.com\/blog\/wp-json\/wp\/v2\/tags?post=4402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}